Work productivity loss and fatigue in psoriatic arthritis

Journal of Rheumatology

Volumn 41, Issue 8, 2014, Pages 1670-1674

  Walsh, Jessica A ^a,b   McFadden, Molly L ^a   Morgan, Michael D ^a,b   Sawitzke, Allen D ^a   Duffin, Kristina Callis ^a   Krueger, Gerald G ^a   Clegg, Daniel O ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (United States)

Author keywords

Disability; Fatigue; Psoriatic arthritis; Quality of Life; Work

Indexed keywords

ADULT; ARTICLE; BACKACHE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BODY SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EMPLOYEE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRURITUS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; WORK DISABILITY; ABSENTEEISM; COMPLICATION; CROSS-SECTIONAL STUDY; DISABILITY; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODUCTIVITY; QUESTIONNAIRE; REGISTER; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED STATES; WORKLOAD;

ABSENTEEISM; ADULT; ARTHRITIS, PSORIATIC; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; EFFICIENCY; FATIGUE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UTAH; WORKLOAD;

EID: 84905459986     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140259     Document Type: Article

References (18)

1. Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology 2012;51:275-83.
2. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One 2012;7:e52935.
3. Kvamme MK, Lie E, Kvien TK, Kristiansen IS. Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry. Rheumatology 2012;51:1618-27.
4. Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD. Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 2009;68:1553-58.
5. Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 2012;42:32-41.
6. Lerner D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care 2001;39:72-85.
7. Gladman DD; ACCLAIM Study Investigators, Sampalis JS, Illouz O, Guérette B. Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study. J Rheumatol 2010;37:1898-906.
8. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQOL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9.
9. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
10. Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, et al. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol 2013;40:287-93.
11. Krueger GG. New method being developed for assessing psoriasis. National Psoriasis Foundation Forum 1999;5:4-5.
12. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
13. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
14. Fitzgerald O, Chandran V. Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol 2012;39:427-30.
15. Maes M, Twisk FN, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom 2012;81:286-95.
16. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002;5:375-88.
17. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010;29:10-15.
18. Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, et al. Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 2012;64:1593-601.